Description
What is EPO (High-Dose)??
This 10,000 IU/vial high-dose formulation of recombinant human erythropoietin (rhEPO) is designed for research protocols requiring elevated EPO concentrations — dose-escalation studies, supraphysiological receptor saturation kinetics, high-burden anaemia models, or multi-arm concentration-response assays. EPO binds the homodimeric EPOR, activating JAK2/STAT5, PI3K/Akt, and MAPK pathways to stimulate red blood cell differentiation, survival, and haemoglobin synthesis. EPOR expression in non-haematopoietic tissues also supports neuroprotection and cardioprotection research.






Reviews
There are no reviews yet.